Biogen Trades At 12-Month High Following Alzheimer's Drug Success, US$900-Million Settlement On Kickback Lawsuit

Fresh off a US$900 million settlement agreement, Biogen, Inc (Nasdaq: BIIB) announced positive topline results from the phase 3 study

Related Keywords

Japan ,Tokyo ,United States ,Massachusetts ,Michael Bawduniak ,Rachaels Rollins ,Michel Vounatsos ,Biogen Inc Nasdaq ,Nasdaq ,Us Justice Department ,